A Polymorphic Antioxidant Response Element Links NRF2/sMAF Binding to Enhanced MAPT Expression and Reduced Risk of Parkinsonian Disorders.

Citation data:

Cell reports, ISSN: 2211-1247, Vol: 15, Issue: 4, Page: 830-842

Publication Year:
2016
Usage 12
Abstract Views 11
Link-outs 1
Captures 31
Readers 31
Social Media 8
Tweets 5
Shares, Likes & Comments 3
Citations 10
Citation Indexes 10
PMID:
27149848
DOI:
10.1016/j.celrep.2016.03.068
PMCID:
PMC5063658
Author(s):
Wang, Xuting; Campbell, Michelle R; Lacher, Sarah E; Cho, Hye-Youn; Wan, Ma; Crowl, Christopher L; Chorley, Brian N; Bond, Gareth L; Kleeberger, Steven R; Slattery, Matthew; Bell, Douglas A Show More Hide
Publisher(s):
Elsevier BV
Tags:
Biochemistry, Genetics and Molecular Biology
Most Recent Tweet View All Tweets
article description
The NRF2/sMAF protein complex regulates the oxidative stress response by occupying cis-acting enhancers containing an antioxidant response element (ARE). Integrating genome-wide maps of NRF2/sMAF occupancy with disease-susceptibility loci, we discovered eight polymorphic AREs linked to 14 highly ranked disease-risk SNPs in individuals of European ancestry. Among these SNPs was rs242561, located within a regulatory region of the MAPT gene (encoding microtubule-associated protein Tau). It was consistently occupied by NRF2/sMAF in multiple experiments and its strong-binding allele associated with higher mRNA levels in cell lines and human brain tissue. Induction of MAPT transcription by NRF2 was confirmed using a human neuroblastoma cell line and a Nrf2-deficient mouse model. Most importantly, rs242561 displayed complete linkage disequilibrium with a highly protective allele identified in multiple GWASs of progressive supranuclear palsy, Parkinson's disease, and corticobasal degeneration. These observations suggest a potential role for NRF2/sMAF in tauopathies and a possible role for NRF2 pathway activators in disease prevention.